Cargando…
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
INTRODUCTION: Our recent data showed that signal transducers and activators of transcription 1 (STAT1), adenosine deaminase acting on RNA (ADAR), C-C motif chemokine ligand 2 (CCL2), and C-X-C motif chemokine 10 (CXCL10) were significantly elevated in a systemic lupus erythematosus (SLE) cohort comp...
Autores principales: | Dominguez-Gutierrez, Paul R, Ceribelli, Angela, Satoh, Minoru, Sobel, Eric S, Reeves, Westley H, Chan, Edward KL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978465/ https://www.ncbi.nlm.nih.gov/pubmed/24460726 http://dx.doi.org/10.1186/ar4451 |
Ejemplares similares
-
Hydroxychloroquine/mycophenolate mofetil/prednisone: SARS-CoV-2 infection: case report
Publicado: (2021) -
Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020) -
Mycophenolate-mofetil/prednisone: Lack of efficacy: case report
Publicado: (2021) -
Mycophenolate-mofetil/prednisone: Recurrence of COVID-19: case report
Publicado: (2020) -
Mycophenolate mofetil/prednisone/sirolimus: Various toxicities: case report
Publicado: (2020)